Measuring the Impact of the Food and Drug Administration (Fda) Unapproved Drug Initiative (Udi) on Drug Prices and Expenditures

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.1555
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV